Bracket Announces Platform Updates
April 20, 2016, Wayne, PA – Bracket, a leading clinical trial specialty services provider, announced platform updates to Bracket eCOATM and Bracket RTSMTM to include native support for SMS messaging with patients and other stakeholders in clinical research programs. This important update expands the medication compliance and adherence functionality across Bracket’s eClinical portfolio, and provides an effective solution for supporting patients participating in clinical trials. “Patient communication tools are an essential component of effective patient engagement programs, and these updates reinforce our commitment to improving the patient experience in research programs through progressive methods offered by healthcare IT,” said Jeff Kinell, Chief Executive Officer for Bracket. There is increasing evidence that text messaging is an effective and scalable tool for improving medication adherence amongst patients. Historically, interventions targeting medication adherence involved multimodal, resource intensive combinations that may not be feasible in clinical practice. Contrarily, text messaging offers confidential and unobtrusive support, instantaneous relay of information and boundless reach. A study review in the February issue of JAMA Internal Medicine reported:
- A 50 percent increase in adherence rates when text messaging was utilized
- High acceptance and satisfaction levels among most participants
- Text messaging support as a valuable reminder with ease of use
“Improving the way we engage with patients in clinical trials is an important goal, and introducing a simple and effective communication tool like SMS will help us achieve both better compliance and adherence in clinical trials,” stated Dr. David Daniel, Chief Medical Officer for Bracket. In addition to direct-to-patient communication, the mobile text messaging platform can be leveraged to issue alerts to clinical trial sites, study sponsors, and CROs who are working with Bracket’s RTSM and eCOA tools. Bracket launched the initial SMS platform in 2015, and will continue to integrate patient engagement tools across the product line through a series of product releases and integrations in 2016.
About Bracket
Bracket, with seven offices and more than 500 employees worldwide, is a specialty services provider dedicated to helping biopharmaceutical sponsors and contract research organizations increase the power of their clinical research data by leveraging core competencies in Science, Technology, and Service. Bracket eCOA is a flexible platform for electronic clinical outcomes assessments. Bracket RTSM is a best-in-breed, scalable and configurable clinical IRT solution for the life sciences industry. Bracket Rater Training and Quality Assurance improve outcomes through customized training and quality assurance programs. Learn more about Bracket at
www.bracketglobal.com
.
Truqap Combination Shines in Phase III Trial for Prostate Cancer
November 26th 2024Data from the CAPItello-281 trial show Truqap alongside abiraterone and androgen deprivation therapy achieved a statistically significant and clinically meaningful improvement in radiographic progression-free survival.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
